Title of Collaborative Activity: |
Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of DEA Scheduling Recommendations to the FDA |
Description of Collaborative Activity: |
HHS depends upon NIDA contracts to generate the in vitro and animal behavioral data that are required to support the domestic scheduling of new street drugs. The long-standing agreement is that DEA provides the drugs (or the funds to cover drug synthesis) to NIDA, and NIDA covers the cost of pharmacological testing. |
Type of Collaborative Activity: |
Select Type of Collaborative Activity
|
Year the Collaborative Activity Originated: |
Unknown |
NIH Participating Institutes/Centers/Office of the Director: |
NIDA |
HHS Agency Collaborators on this Activity: |
FDA, OS |
